Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Brunelli

Showing results (201-210 of 409) with videos related to

Pageof 41
Sort By:
Clinical Genitourinary Cancer|January 18, 2018
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Emilio Bria, et al.
Urologia Internationalis|May 28, 2020
Association between Basal Total Testosterone Levels and Prostate Cancer D'Amico Risk ClassesAlessandro Tafuri, Marco Sebben, Marco Pirozzi, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|April 29, 2024
Forensic value of soft tissue detachments from the hyoid bone in death due to strangulation asphyxiaGiovanna Del Balzo, Guido Pelletti, Dario Raniero, et al.
Minerva Urology and Nephrology|July 24, 2023
Validation of real-time prostatic biopsies evaluation with fluorescence laser confocal microscopyStefano Gobbo, Albino Eccher, Sebastian Gallina, et al.
Urologia Internationalis|February 5, 2016
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical ProstatectomyAntonio Benito Porcaro, Aldo Petroziello, Matteo Brunelli, et al.
Plos One|June 19, 2015
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary CancersLuisa Carbognin, Sara Pilotto, Michele Milella, et al.
Future Oncology (London, England)|January 10, 2015
Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?Sebastiano Buti, Chiara Ciccarese, Daniele Zanoni, et al.
Asian Journal of Urology|December 22, 2017
Prostate cancer volume associates with preoperative plasma levels of testosterone that independently predicts high grade tumours which show low densities (quotient testosterone/tumour volume)Antonio B Porcaro, Aldo Petrozziello, Matteo Brunelli, et al.
Histology and Histopathology|March 8, 2014
Adenocarcinoma of the paraurethral glands: a case reportFrancesco Massari, Chiara Ciccarese, Alessandra Modena, et al.
Clinical Genitourinary Cancer|January 28, 2024
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing EvidenceFrancesco Ditonno, Alberto Bianchi, Sarah Malandra, et al.
Pageof 41

Showing results (201-210 of 409) with videos related to

Sort By:
Pageof 41
Clinical Genitourinary Cancer|January 18, 2018
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Emilio Bria, et al.
Urologia Internationalis|May 28, 2020
Association between Basal Total Testosterone Levels and Prostate Cancer D'Amico Risk ClassesAlessandro Tafuri, Marco Sebben, Marco Pirozzi, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|April 29, 2024
Forensic value of soft tissue detachments from the hyoid bone in death due to strangulation asphyxiaGiovanna Del Balzo, Guido Pelletti, Dario Raniero, et al.
Minerva Urology and Nephrology|July 24, 2023
Validation of real-time prostatic biopsies evaluation with fluorescence laser confocal microscopyStefano Gobbo, Albino Eccher, Sebastian Gallina, et al.
Urologia Internationalis|February 5, 2016
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical ProstatectomyAntonio Benito Porcaro, Aldo Petroziello, Matteo Brunelli, et al.
Plos One|June 19, 2015
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary CancersLuisa Carbognin, Sara Pilotto, Michele Milella, et al.
Future Oncology (London, England)|January 10, 2015
Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?Sebastiano Buti, Chiara Ciccarese, Daniele Zanoni, et al.
Asian Journal of Urology|December 22, 2017
Prostate cancer volume associates with preoperative plasma levels of testosterone that independently predicts high grade tumours which show low densities (quotient testosterone/tumour volume)Antonio B Porcaro, Aldo Petrozziello, Matteo Brunelli, et al.
Histology and Histopathology|March 8, 2014
Adenocarcinoma of the paraurethral glands: a case reportFrancesco Massari, Chiara Ciccarese, Alessandra Modena, et al.
Clinical Genitourinary Cancer|January 28, 2024
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing EvidenceFrancesco Ditonno, Alberto Bianchi, Sarah Malandra, et al.
Pageof 41